DEA to amend legislation over 2C-T-7 and BZP

HerrSchnaufer

Bluelighter
Joined
May 13, 2009
Messages
171
SUMMARY: The Drug Enforcement Administration (DEA) is correcting a
notice of proposed rulemaking that appeared in the Federal Register of
September 8, 2003. The proposed rule pertained to the scheduling of N-
Benzylpiperazine (BZP), and contained an error regarding the potency of
BZP relative to amphetamine. Although DEA used the correct figures in
arriving at its scheduling determination, the agency is publishing this
correction to provide an official statement of the actual figures. This
correction does not address the scheduling of 2,5-dimethoxy-4-(n)-
propylthiophenethylamine (2C-T-7) which was also placed into schedule I
as a result of the above cited rulemaking.

DATES: This correction is effective August 6, 2010 without further
action.

SUMMARY: The Drug Enforcement Administration (DEA) is correcting a
final rule that appeared in the Federal Register of March 18, 2004. The
final rule pertained to the scheduling of N-Benzylpiperazine (BZP), and
contained an error regarding the potency of BZP relative to
amphetamine. Although DEA used the correct figures in arriving at its
scheduling determination, the agency is publishing this correction to
provide an official statement of the actual figures. This correction
does not address the scheduling of 2,5-dimethoxy-4-(n)-
propylthiophenethylamine (2C-T-7) which was also placed into schedule I
as a result of the above cited rulemaking.

DATES: This correction is effective August 6, 2010 without further
action.

Taken from http://edocket.access.gpo.gov/2010/2010-19345.htm and http://edocket.access.gpo.gov/2010/2010-19348.htm
 
See, this is the kind of stuff that would be in the Microgram if there still was a Microgram or if I knew a website where I could read the LEO-only Microgram :\
 
Top